Leukocyte immunoglobulin-like receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
**[[1g0x]], [[1ufu]] – hLIR-1 ligand-binding domain D1D2– human <br /> | **[[1g0x]], [[1ufu]] – hLIR-1 ligand-binding domain D1D2– human <br /> | ||
**[[1ugn]], [[1vdg]] – hLIR-1 ligand-binding domain D1D2 (mutant) <br /> | **[[1ugn]], [[1vdg]] – hLIR-1 ligand-binding domain D1D2 (mutant) <br /> | ||
**[[6ewa]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | **[[4ll9]] – hLIR-1 ligand-binding domain D3D4 <br /> | ||
*LIR-1 complexes | |||
**[[1p7q]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | |||
**[[5knm]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | |||
**[[4no0]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + lymphocyte-specific protein peptide<br /> | |||
**[[3d2u]] – hLIR-1 ligand-binding domain D1D2 + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | |||
**[[6ewa]], [[6ewc]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | |||
**[[6ewo]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + desmuslin peptide<br /> | **[[6ewo]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + desmuslin peptide<br /> | ||
**[[ | **[[6aee]], [[6k60]] – hLIR-1 ligand-binding domain D1D2D3D4 + class I MHC + β-2 microglobulin + histone peptide<br /> | ||
*LIR-2 | *LIR-2 | ||
Line 21: | Line 29: | ||
**[[4lla]] – hLIR-2 ligand-binding domain D3D4 <br /> | **[[4lla]] – hLIR-2 ligand-binding domain D3D4 <br /> | ||
**[[2otp]] – hLIR-2 ligand-binding domain D1D2 <br /> | **[[2otp]] – hLIR-2 ligand-binding domain D1D2 <br /> | ||
**[[6bcs]] – hLIR-2 ligand-binding domain D1D2 + benzamidine<br /> | |||
**[[6aed]] – hLIR-2 ligand-binding domain D1D2D3D4 (mutant)<br /> | |||
**[[2dyp]] – hLIR-2 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + H2A peptide<br /> | **[[2dyp]] – hLIR-2 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + H2A peptide<br /> | ||
Line 26: | Line 36: | ||
**[[3q2c]] – hLIR-4 N-terminal domain <br /> | **[[3q2c]] – hLIR-4 N-terminal domain <br /> | ||
**[[6k7o]] – hLIR-4 N-terminal domain + antibody <br /> | |||
*LIR-5 | *LIR-5 | ||
Line 31: | Line 42: | ||
**[[3p2t]] – hLIR-5 ligand-binding domain D1D2 <br /> | **[[3p2t]] – hLIR-5 ligand-binding domain D1D2 <br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |